Parkwalk Advisors
Parkwalk Advisors Ltd is the UK's most active investor in university spinouts, managing around £500 million in assets as the leading Enterprise Investment Scheme (EIS) fund manager focused on knowledge-intensive technology businesses spun out of leading UK universities including Oxford, Cambridge, Imperial College London, Bristol, Manchester, Leeds and Sheffield. Founded in 2009 and acquired by IP Group plc in 2017, Parkwalk has backed over 200 university spinouts and delivered more than £200 million in cash returns to its EIS investors across 70+ exits. The firm is authorised and regulated by the UK Financial Conduct Authority under firm reference number 502237. Its flagship Opportunities EIS Fund has raised the largest growth EIS fund in the UK market for five of the past six tax years.
Key facts
Recent exits
Coverage notes
2 funds tracked, 61 portfolio companies (50 active · 11 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
61 companiesFunds & portfolio
Every fund Parkwalk Advisors has raised, with its portfolio companies. Hand-checked from public filings.
Parkwalk Knowledge Intensive EIS FundVC2021 · 5yr€83M4 active
Unrealized
4 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| MedTech |  UK | 2022 | |
| Deep Tech | UK | 2023 | |
| HealthTech | UK | 2024 | |
| MedTech | UK | 2022 |
UK· Entry 2022UK· Entry 2023UK· Entry 2024UK· Entry 2022Parkwalk Opportunities EIS FundVC2009 · 17yr€585M46 active · 11 realized
Unrealized
46 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Deep Tech | UK | 2016 | |
| Aerospace & Defence | UK | 2015 | |
| Deep Tech | UK | – | |
| Software | UK | – | |
| ClimateTech | UK | – | |
| MedTech | UK | 2017 | |
| ClimateTech | UK | 2022 | |
| HealthTech | UK | 2021 | |
| ClimateTech | UK | 2018 | |
| ClimateTech | UK | 2024 | |
| Deep Tech | UK | 2022 | |
| Biotech | United Kingdom | 2025 | |
| ClimateTech | UK | 2021 | |
| MedTech | UK | 2021 | |
| Cybersecurity | UK | 2022 | |
| Biotech | United Kingdom | 2026 | |
| Deep Tech | UK | 2026 | |
| DevTools | UK | 2022 | |
| ClimateTech | UK | 2018 | |
| MedTech | United Kingdom | 2019 | |
| Deep Tech | UK | 2017 | |
| Biotech | UK | 2018 | |
| MedTech | United Kingdom | 2026 | |
| Deep Tech | UK | 2026 | |
| ClimateTech | UK | 2024 | |
| AI/ML | UK | 2016 | |
| MedTech | UK | 2024 | |
| AgTech | UK | 2018 | |
| Biotech | UK | 2021 | |
| ClimateTech | UK | 2024 | |
| FoodTech | UK | 2014 | |
| AgTech | UK | 2025 | |
| Deep Tech | UK | 2020 | |
| Deep Tech | UK | 2018 | |
| Deep Tech | UK | 2017 | |
| Deep Tech | UK | 2018 | |
| Biotech | UK | 2020 | |
| Deep Tech | UK | 2026 | |
| Biotech | UK | 2020 | |
| Deep Tech | UK | 2017 | |
| Biotech | UK | 2025 | |
| Biotech | UK | 2022 | |
| Deep Tech | UK | 2024 | |
| ClimateTech | UK | 2020 | |
| Deep Tech | UK | 2026 | |
| ClimateTech | United Kingdom | 2024 |
UK· Entry 2016UK· Entry 2015UKUKUKUK· Entry 2017UK· Entry 2022UK· Entry 2021UK· Entry 2018UK· Entry 2024UK· Entry 2022United Kingdom· Entry 2025UK· Entry 2021UK· Entry 2021UK· Entry 2022United Kingdom· Entry 2026UK· Entry 2026UK· Entry 2022UK· Entry 2018United Kingdom· Entry 2019UK· Entry 2017UK· Entry 2018United Kingdom· Entry 2026UK· Entry 2026UK· Entry 2024UK· Entry 2016UK· Entry 2024UK· Entry 2018UK· Entry 2021UK· Entry 2024UK· Entry 2014UK· Entry 2025UK· Entry 2020UK· Entry 2018UK· Entry 2017UK· Entry 2018UK· Entry 2020UK· Entry 2026UK· Entry 2020UK· Entry 2017UK· Entry 2025UK· Entry 2022UK· Entry 2024UK· Entry 2020UK· Entry 2026United Kingdom· Entry 2024Realized
11 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| AI/ML | UK | – | 2023 | – | – | – | |
| Energy | UK | – | 2017 | – | – | – | |
| Deep Tech | UK | 2018 | 2024 | – | – | – | |
| HealthTech | UK | 2017 | 2025 | Trade Sale | – | ||
| Software | UK | 2015 | 2025 | Trade Sale | – | ||
| Deep Tech | UK | 2020 | 2022 | Trade Sale | – | ||
| Biotech | UK | 2013 | 2017 | Secondary | – | – | |
| AI/ML | UK | 2014 | 2019 | Trade Sale | – | ||
| Biotech | UK | 2019 | 2023 | Trade Sale | – | ||
| AI/ML | UK | 2014 | 2015 | Trade Sale | – | ||
| Mobility | UK | 2012 | 2021 | Trade Sale | – |
UKUKUK· Entry 2018Saved GPs appear in your watchlist, one click from your workspace.
About Parkwalk Advisors
Parkwalk Advisors is the UK's most active university spinout investor with approximately £450 million of assets under management as of December 2024 (£483.4 million deployed across 200 companies by June 2025), headquartered in London at 3 Pancras Square, King's Cross. The firm was founded in 2009 as a university spinout EIS specialist before being acquired by IP Group plc in 2017, now operating as a wholly-owned subsidiary of IP Group plc (LSE: IPO). Parkwalk completed 41 deals in 2024 (54 with IP Group).
Investment thesis
Parkwalk Advisors deploys capital through 15 plus EIS funds across two main families: the Opportunities EIS Fund (annual vintages since 2011) and the Knowledge Intensive EIS Fund (Funds I-V since 2021). The platform provides EIS and Knowledge Intensive EIS fund management with early-stage to scale-up co-investment alongside parent IP Group in university spinouts. Sector focus spans deep tech (AI, quantum, hardware, advanced materials), healthtech and digital health and life sciences and cleantech (agtech, future mobility, energy). Geographic deployment is UK-only with focus on spinouts from Oxford, Cambridge, Imperial, UCL, Manchester, Bristol, Southampton and Leeds.
Recent activity
Recent realised exits include insurtech and AI (2025) and quantum computing (2025, co-investment with Oxford Capital in Oxford Ionics). Recent acquisitions include quantum computing follow-on (2026), hardware and metrology (2026) and hardware seed (2026). The platform continues active deployment across the UK university spinout franchise. Detailed buyer names and multiple data available on Pro at €29/month.
Investment team
Senior partners. Hand-checked from public filings and the firm's own site.
Similar firms
Other private equity firms tracked on GP Intel.
United Kingdom·€580M
United Kingdom·€527M
United Kingdom·€515M
United Kingdom·€702M
United Kingdom·€447M
United Kingdom·€421M
United Kingdom·€386M
United Kingdom·€850M
United Kingdom·€298M
United Kingdom·€294M
United Kingdom·€293M
United Kingdom·€878MGet the full picture on Parkwalk Advisors.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in